Pre-order Enquiry
Request Free Sample
Global Mumps Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
SKU ID : GIR-21184052 | Publishing Date : 01-Jul-2022 | No. of pages : 126
Detailed TOC of Global Mumps Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
1 Market Overview1.1 Mumps Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mumps Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Child
1.2.3 Adult
1.3 Market Analysis by Application
1.3.1 Overview: Global Mumps Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Mumps Vaccine Market Size & Forecast
1.4.1 Global Mumps Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mumps Vaccine Sales in Volume (2017-2028)
1.4.3 Global Mumps Vaccine Price (2017-2028)
1.5 Global Mumps Vaccine Production Capacity Analysis
1.5.1 Global Mumps Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Mumps Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mumps Vaccine Market Drivers
1.6.2 Mumps Vaccine Market Restraints
1.6.3 Mumps Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 MedImmune
2.1.1 MedImmune Details
2.1.2 MedImmune Major Business
2.1.3 MedImmune Mumps Vaccine Product and Services
2.1.4 MedImmune Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Mumps Vaccine Product and Services
2.2.4 Johnson & Johnson Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Mumps Vaccine Product and Services
2.3.4 Merck & Co., Inc. Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Mumps Vaccine Product and Services
2.4.4 Sanofi Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Mumps Vaccine Product and Services
2.5.4 Serum Institute of India Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Mumps Vaccine Product and Services
2.6.4 Bavarian Nordic Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma India
2.7.1 Astellas Pharma India Details
2.7.2 Astellas Pharma India Major Business
2.7.3 Astellas Pharma India Mumps Vaccine Product and Services
2.7.4 Astellas Pharma India Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CSL Limited
2.8.1 CSL Limited Details
2.8.2 CSL Limited Major Business
2.8.3 CSL Limited Mumps Vaccine Product and Services
2.8.4 CSL Limited Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Emergent BioSolutions
2.9.1 Emergent BioSolutions Details
2.9.2 Emergent BioSolutions Major Business
2.9.3 Emergent BioSolutions Mumps Vaccine Product and Services
2.9.4 Emergent BioSolutions Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Mumps Vaccine Product and Services
2.10.4 GlaxoSmithKline Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Panacea Biotec, Ltd.
2.11.1 Panacea Biotec, Ltd. Details
2.11.2 Panacea Biotec, Ltd. Major Business
2.11.3 Panacea Biotec, Ltd. Mumps Vaccine Product and Services
2.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Biological E Limited
2.12.1 Biological E Limited Details
2.12.2 Biological E Limited Major Business
2.12.3 Biological E Limited Mumps Vaccine Product and Services
2.12.4 Biological E Limited Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bharat Biotech Ltd.
2.13.1 Bharat Biotech Ltd. Details
2.13.2 Bharat Biotech Ltd. Major Business
2.13.3 Bharat Biotech Ltd. Mumps Vaccine Product and Services
2.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novavax, Inc.
2.14.1 Novavax, Inc. Details
2.14.2 Novavax, Inc. Major Business
2.14.3 Novavax, Inc. Mumps Vaccine Product and Services
2.14.4 Novavax, Inc. Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Mumps Vaccine Product and Services
2.15.4 Novartis Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sinovac Biotech, Ltd.
2.16.1 Sinovac Biotech, Ltd. Details
2.16.2 Sinovac Biotech, Ltd. Major Business
2.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
2.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Incepta Vaccine Limited
2.17.1 Incepta Vaccine Limited Details
2.17.2 Incepta Vaccine Limited Major Business
2.17.3 Incepta Vaccine Limited Mumps Vaccine Product and Services
2.17.4 Incepta Vaccine Limited Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Valneva SE
2.18.1 Valneva SE Details
2.18.2 Valneva SE Major Business
2.18.3 Valneva SE Mumps Vaccine Product and Services
2.18.4 Valneva SE Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 VBI Vaccines
2.19.1 VBI Vaccines Details
2.19.2 VBI Vaccines Major Business
2.19.3 VBI Vaccines Mumps Vaccine Product and Services
2.19.4 VBI Vaccines Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 PT Bio Farma
2.20.1 PT Bio Farma Details
2.20.2 PT Bio Farma Major Business
2.20.3 PT Bio Farma Mumps Vaccine Product and Services
2.20.4 PT Bio Farma Mumps Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mumps Vaccine Breakdown Data by Manufacturer
3.1 Global Mumps Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mumps Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mumps Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Mumps Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Mumps Vaccine Manufacturer Market Share in 2021
3.5 Global Mumps Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mumps Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mumps Vaccine Market Size by Region
4.1.1 Global Mumps Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Mumps Vaccine Revenue by Region (2017-2028)
4.2 North America Mumps Vaccine Revenue (2017-2028)
4.3 Europe Mumps Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Mumps Vaccine Revenue (2017-2028)
4.5 South America Mumps Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Mumps Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mumps Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Mumps Vaccine Revenue by Type (2017-2028)
5.3 Global Mumps Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mumps Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Mumps Vaccine Revenue by Application (2017-2028)
6.3 Global Mumps Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mumps Vaccine Sales by Type (2017-2028)
7.2 North America Mumps Vaccine Sales by Application (2017-2028)
7.3 North America Mumps Vaccine Market Size by Country
7.3.1 North America Mumps Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Mumps Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mumps Vaccine Sales by Type (2017-2028)
8.2 Europe Mumps Vaccine Sales by Application (2017-2028)
8.3 Europe Mumps Vaccine Market Size by Country
8.3.1 Europe Mumps Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Mumps Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mumps Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Mumps Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Mumps Vaccine Market Size by Region
9.3.1 Asia-Pacific Mumps Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mumps Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mumps Vaccine Sales by Type (2017-2028)
10.2 South America Mumps Vaccine Sales by Application (2017-2028)
10.3 South America Mumps Vaccine Market Size by Country
10.3.1 South America Mumps Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Mumps Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mumps Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Mumps Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Mumps Vaccine Market Size by Country
11.3.1 Middle East & Africa Mumps Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mumps Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mumps Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mumps Vaccine
12.3 Mumps Vaccine Production Process
12.4 Mumps Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mumps Vaccine Typical Distributors
13.3 Mumps Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Mumps Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
List of TablesTable 1. Global Mumps Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Mumps Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. MedImmune Basic Information, Manufacturing Base and Competitors
Table 4. MedImmune Major Business
Table 5. MedImmune Mumps Vaccine Product and Services
Table 6. MedImmune Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Mumps Vaccine Product and Services
Table 10. Johnson & Johnson Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co., Inc. Major Business
Table 13. Merck & Co., Inc. Mumps Vaccine Product and Services
Table 14. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Mumps Vaccine Product and Services
Table 18. Sanofi Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute of India Major Business
Table 21. Serum Institute of India Mumps Vaccine Product and Services
Table 22. Serum Institute of India Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 24. Bavarian Nordic Major Business
Table 25. Bavarian Nordic Mumps Vaccine Product and Services
Table 26. Bavarian Nordic Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma India Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma India Major Business
Table 29. Astellas Pharma India Mumps Vaccine Product and Services
Table 30. Astellas Pharma India Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 32. CSL Limited Major Business
Table 33. CSL Limited Mumps Vaccine Product and Services
Table 34. CSL Limited Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 36. Emergent BioSolutions Major Business
Table 37. Emergent BioSolutions Mumps Vaccine Product and Services
Table 38. Emergent BioSolutions Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 40. GlaxoSmithKline Major Business
Table 41. GlaxoSmithKline Mumps Vaccine Product and Services
Table 42. GlaxoSmithKline Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Panacea Biotec, Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Panacea Biotec, Ltd. Major Business
Table 45. Panacea Biotec, Ltd. Mumps Vaccine Product and Services
Table 46. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 48. Biological E Limited Major Business
Table 49. Biological E Limited Mumps Vaccine Product and Services
Table 50. Biological E Limited Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Bharat Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Bharat Biotech Ltd. Major Business
Table 53. Bharat Biotech Ltd. Mumps Vaccine Product and Services
Table 54. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novavax, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Novavax, Inc. Major Business
Table 57. Novavax, Inc. Mumps Vaccine Product and Services
Table 58. Novavax, Inc. Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Novartis Basic Information, Manufacturing Base and Competitors
Table 60. Novartis Major Business
Table 61. Novartis Mumps Vaccine Product and Services
Table 62. Novartis Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Sinovac Biotech, Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Sinovac Biotech, Ltd. Major Business
Table 65. Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
Table 66. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Incepta Vaccine Limited Basic Information, Manufacturing Base and Competitors
Table 68. Incepta Vaccine Limited Major Business
Table 69. Incepta Vaccine Limited Mumps Vaccine Product and Services
Table 70. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Valneva SE Basic Information, Manufacturing Base and Competitors
Table 72. Valneva SE Major Business
Table 73. Valneva SE Mumps Vaccine Product and Services
Table 74. Valneva SE Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. VBI Vaccines Basic Information, Manufacturing Base and Competitors
Table 76. VBI Vaccines Major Business
Table 77. VBI Vaccines Mumps Vaccine Product and Services
Table 78. VBI Vaccines Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. PT Bio Farma Basic Information, Manufacturing Base and Competitors
Table 80. PT Bio Farma Major Business
Table 81. PT Bio Farma Mumps Vaccine Product and Services
Table 82. PT Bio Farma Mumps Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Mumps Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Mumps Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Mumps Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Mumps Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Mumps Vaccine Production Site of Key Manufacturer
Table 88. Mumps Vaccine New Entrant and Capacity Expansion Plans
Table 89. Mumps Vaccine Mergers & Acquisitions in the Past Five Years
Table 90. Global Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 91. Global Mumps Vaccine Sales by Region (2023-2028) & (K Units)
Table 92. Global Mumps Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Mumps Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Global Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Global Mumps Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Mumps Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Mumps Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 99. Global Mumps Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 100. Global Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Global Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Global Mumps Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Mumps Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Mumps Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 105. Global Mumps Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 106. North America Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 107. North America Mumps Vaccine Sales by Country (2023-2028) & (K Units)
Table 108. North America Mumps Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Mumps Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 111. North America Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 112. North America Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 113. North America Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 114. Europe Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 115. Europe Mumps Vaccine Sales by Country (2023-2028) & (K Units)
Table 116. Europe Mumps Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Mumps Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 119. Europe Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 120. Europe Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 121. Europe Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Mumps Vaccine Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Mumps Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Mumps Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 130. South America Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 131. South America Mumps Vaccine Sales by Country (2023-2028) & (K Units)
Table 132. South America Mumps Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Mumps Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 135. South America Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 136. South America Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 137. South America Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Mumps Vaccine Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Mumps Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Mumps Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Mumps Vaccine Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Mumps Vaccine Sales by Application (2023-2028) & (K Units)
Table 146. Mumps Vaccine Raw Material
Table 147. Key Manufacturers of Mumps Vaccine Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Mumps Vaccine Typical Distributors
Table 151. Mumps Vaccine Typical Customers
List of Figures
Figure 1. Mumps Vaccine Picture
Figure 2. Global Mumps Vaccine Revenue Market Share by Type in 2021
Figure 3. Child
Figure 4. Adult
Figure 5. Global Mumps Vaccine Revenue Market Share by Application in 2021
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Global Mumps Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Mumps Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Mumps Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Mumps Vaccine Price (2017-2028) & (US$/Unit)
Figure 12. Global Mumps Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Mumps Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Mumps Vaccine Market Drivers
Figure 15. Mumps Vaccine Market Restraints
Figure 16. Mumps Vaccine Market Trends
Figure 17. Global Mumps Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Mumps Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Mumps Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Mumps Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Mumps Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Mumps Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Mumps Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Mumps Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Mumps Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Mumps Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Mumps Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Mumps Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Mumps Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Mumps Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Mumps Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Mumps Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Mumps Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Mumps Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Mumps Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Mumps Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Mumps Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Mumps Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Mumps Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Mumps Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Mumps Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Mumps Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Mumps Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Mumps Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Mumps Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Mumps Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Mumps Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Mumps Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Mumps Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Mumps Vaccine
Figure 77. Mumps Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Keyplayers in Global Mumps Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
MedImmuneJohnson & Johnson
Merck & Co., Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec, Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax, Inc.
Novartis
Sinovac Biotech, Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Request Sample
Request Discount
